A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-αγ agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models
Gespeichert in:
| Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2002-04, Vol.51 (4), p.1083 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 4 |
| container_start_page | 1083 |
| container_title | Diabetes (New York, N.Y.) |
| container_volume | 51 |
| creator | Etgen, Garret J Oldham, Brian A Johnson, William T Broderick, Carol L Montrose, Chahrzad R Brozinick, Joseph T Misener, Elizabeth A Bean, James S Bensch, William R Brooks, Dawn A Shuker, Anthony J Rito, Christopher J McCarthy, James R Ardecky, Robert J Tyhonas, John S Dana, Sharon L Bilakovics, James M Paterniti, Jr., James R Ogilvie, Kathleen M Liu, Sha Kauffman, Raymond F |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracgeneralonefile_A84721248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A84721248</galeid><sourcerecordid>A84721248</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1458-cf92158553f1c60090cfaf0828b4c40fb51f50937592ad1d5f908d663dcc3b2c3</originalsourceid><addsrcrecordid>eNptkE1uGzEMhWeRAs1P76BlFxlA86PxTHeG0aQFDGTTLLoyOBQ1VqORDEl242MVvUdO0wOUbrtoAIMLCcT33iN5UVxKWdVltRgWb4urlL5JKTuuy-LXUmSwLkTSIm8pwu4oTIinv5gpwxicRZGOXscw04c_fb0HJ3YUw7NN3BS7yJBhbQ6xBMz2AJntIiHtTq2XHy8_BUzB25TF-mvbqU72AmZyNrCIkrA-7Z31LEnMgEcS4LXQFkbKnL89ctzkjkizBfF9ax0JO3PuwfpJIERtwwES7h1EEW16EobnCPHkzOMRsrlFnnoOmly6Kd4YcIne_Xuvi8e7j19Wn8r1w_3n1XJdTlWr-hLNUFeqV6oxFXZSDhINGNnX_dhiK82oKqPk0CzUUIOutDKD7HXXNRqxGWtsrovbv74TONpYb0KOgBN5vpULngzvsVn27aKu6rZnvDyDc2leG8_x71_xjGR6zhPsU9r09-tX6O05FINzNNGGt149_If_BqZguT0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-αγ agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Etgen, Garret J ; Oldham, Brian A ; Johnson, William T ; Broderick, Carol L ; Montrose, Chahrzad R ; Brozinick, Joseph T ; Misener, Elizabeth A ; Bean, James S ; Bensch, William R ; Brooks, Dawn A ; Shuker, Anthony J ; Rito, Christopher J ; McCarthy, James R ; Ardecky, Robert J ; Tyhonas, John S ; Dana, Sharon L ; Bilakovics, James M ; Paterniti, Jr., James R ; Ogilvie, Kathleen M ; Liu, Sha ; Kauffman, Raymond F</creator><creatorcontrib>Etgen, Garret J ; Oldham, Brian A ; Johnson, William T ; Broderick, Carol L ; Montrose, Chahrzad R ; Brozinick, Joseph T ; Misener, Elizabeth A ; Bean, James S ; Bensch, William R ; Brooks, Dawn A ; Shuker, Anthony J ; Rito, Christopher J ; McCarthy, James R ; Ardecky, Robert J ; Tyhonas, John S ; Dana, Sharon L ; Bilakovics, James M ; Paterniti, Jr., James R ; Ogilvie, Kathleen M ; Liu, Sha ; Kauffman, Raymond F</creatorcontrib><identifier>ISSN: 0012-1797</identifier><language>eng</language><publisher>American Diabetes Association</publisher><subject>Adipose tissue ; Adipose tissues ; Analysis ; Body weight ; Cardiovascular diseases ; Food consumption ; Genetic aspects ; Glucose tolerance test ; Glucose tolerance tests ; Liver ; Measurement ; Metabolism ; Physiological aspects ; Risk factors ; Type 2 diabetes</subject><ispartof>Diabetes (New York, N.Y.), 2002-04, Vol.51 (4), p.1083</ispartof><rights>COPYRIGHT 2002 American Diabetes Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Etgen, Garret J</creatorcontrib><creatorcontrib>Oldham, Brian A</creatorcontrib><creatorcontrib>Johnson, William T</creatorcontrib><creatorcontrib>Broderick, Carol L</creatorcontrib><creatorcontrib>Montrose, Chahrzad R</creatorcontrib><creatorcontrib>Brozinick, Joseph T</creatorcontrib><creatorcontrib>Misener, Elizabeth A</creatorcontrib><creatorcontrib>Bean, James S</creatorcontrib><creatorcontrib>Bensch, William R</creatorcontrib><creatorcontrib>Brooks, Dawn A</creatorcontrib><creatorcontrib>Shuker, Anthony J</creatorcontrib><creatorcontrib>Rito, Christopher J</creatorcontrib><creatorcontrib>McCarthy, James R</creatorcontrib><creatorcontrib>Ardecky, Robert J</creatorcontrib><creatorcontrib>Tyhonas, John S</creatorcontrib><creatorcontrib>Dana, Sharon L</creatorcontrib><creatorcontrib>Bilakovics, James M</creatorcontrib><creatorcontrib>Paterniti, Jr., James R</creatorcontrib><creatorcontrib>Ogilvie, Kathleen M</creatorcontrib><creatorcontrib>Liu, Sha</creatorcontrib><creatorcontrib>Kauffman, Raymond F</creatorcontrib><title>A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-αγ agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><subject>Adipose tissue</subject><subject>Adipose tissues</subject><subject>Analysis</subject><subject>Body weight</subject><subject>Cardiovascular diseases</subject><subject>Food consumption</subject><subject>Genetic aspects</subject><subject>Glucose tolerance test</subject><subject>Glucose tolerance tests</subject><subject>Liver</subject><subject>Measurement</subject><subject>Metabolism</subject><subject>Physiological aspects</subject><subject>Risk factors</subject><subject>Type 2 diabetes</subject><issn>0012-1797</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNptkE1uGzEMhWeRAs1P76BlFxlA86PxTHeG0aQFDGTTLLoyOBQ1VqORDEl242MVvUdO0wOUbrtoAIMLCcT33iN5UVxKWdVltRgWb4urlL5JKTuuy-LXUmSwLkTSIm8pwu4oTIinv5gpwxicRZGOXscw04c_fb0HJ3YUw7NN3BS7yJBhbQ6xBMz2AJntIiHtTq2XHy8_BUzB25TF-mvbqU72AmZyNrCIkrA-7Z31LEnMgEcS4LXQFkbKnL89ctzkjkizBfF9ax0JO3PuwfpJIERtwwES7h1EEW16EobnCPHkzOMRsrlFnnoOmly6Kd4YcIne_Xuvi8e7j19Wn8r1w_3n1XJdTlWr-hLNUFeqV6oxFXZSDhINGNnX_dhiK82oKqPk0CzUUIOutDKD7HXXNRqxGWtsrovbv74TONpYb0KOgBN5vpULngzvsVn27aKu6rZnvDyDc2leG8_x71_xjGR6zhPsU9r09-tX6O05FINzNNGGt149_If_BqZguT0</recordid><startdate>20020401</startdate><enddate>20020401</enddate><creator>Etgen, Garret J</creator><creator>Oldham, Brian A</creator><creator>Johnson, William T</creator><creator>Broderick, Carol L</creator><creator>Montrose, Chahrzad R</creator><creator>Brozinick, Joseph T</creator><creator>Misener, Elizabeth A</creator><creator>Bean, James S</creator><creator>Bensch, William R</creator><creator>Brooks, Dawn A</creator><creator>Shuker, Anthony J</creator><creator>Rito, Christopher J</creator><creator>McCarthy, James R</creator><creator>Ardecky, Robert J</creator><creator>Tyhonas, John S</creator><creator>Dana, Sharon L</creator><creator>Bilakovics, James M</creator><creator>Paterniti, Jr., James R</creator><creator>Ogilvie, Kathleen M</creator><creator>Liu, Sha</creator><creator>Kauffman, Raymond F</creator><general>American Diabetes Association</general><scope>8GL</scope></search><sort><creationdate>20020401</creationdate><title>A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-αγ agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models</title><author>Etgen, Garret J ; Oldham, Brian A ; Johnson, William T ; Broderick, Carol L ; Montrose, Chahrzad R ; Brozinick, Joseph T ; Misener, Elizabeth A ; Bean, James S ; Bensch, William R ; Brooks, Dawn A ; Shuker, Anthony J ; Rito, Christopher J ; McCarthy, James R ; Ardecky, Robert J ; Tyhonas, John S ; Dana, Sharon L ; Bilakovics, James M ; Paterniti, Jr., James R ; Ogilvie, Kathleen M ; Liu, Sha ; Kauffman, Raymond F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1458-cf92158553f1c60090cfaf0828b4c40fb51f50937592ad1d5f908d663dcc3b2c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adipose tissue</topic><topic>Adipose tissues</topic><topic>Analysis</topic><topic>Body weight</topic><topic>Cardiovascular diseases</topic><topic>Food consumption</topic><topic>Genetic aspects</topic><topic>Glucose tolerance test</topic><topic>Glucose tolerance tests</topic><topic>Liver</topic><topic>Measurement</topic><topic>Metabolism</topic><topic>Physiological aspects</topic><topic>Risk factors</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Etgen, Garret J</creatorcontrib><creatorcontrib>Oldham, Brian A</creatorcontrib><creatorcontrib>Johnson, William T</creatorcontrib><creatorcontrib>Broderick, Carol L</creatorcontrib><creatorcontrib>Montrose, Chahrzad R</creatorcontrib><creatorcontrib>Brozinick, Joseph T</creatorcontrib><creatorcontrib>Misener, Elizabeth A</creatorcontrib><creatorcontrib>Bean, James S</creatorcontrib><creatorcontrib>Bensch, William R</creatorcontrib><creatorcontrib>Brooks, Dawn A</creatorcontrib><creatorcontrib>Shuker, Anthony J</creatorcontrib><creatorcontrib>Rito, Christopher J</creatorcontrib><creatorcontrib>McCarthy, James R</creatorcontrib><creatorcontrib>Ardecky, Robert J</creatorcontrib><creatorcontrib>Tyhonas, John S</creatorcontrib><creatorcontrib>Dana, Sharon L</creatorcontrib><creatorcontrib>Bilakovics, James M</creatorcontrib><creatorcontrib>Paterniti, Jr., James R</creatorcontrib><creatorcontrib>Ogilvie, Kathleen M</creatorcontrib><creatorcontrib>Liu, Sha</creatorcontrib><creatorcontrib>Kauffman, Raymond F</creatorcontrib><collection>Gale In Context: High School</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Etgen, Garret J</au><au>Oldham, Brian A</au><au>Johnson, William T</au><au>Broderick, Carol L</au><au>Montrose, Chahrzad R</au><au>Brozinick, Joseph T</au><au>Misener, Elizabeth A</au><au>Bean, James S</au><au>Bensch, William R</au><au>Brooks, Dawn A</au><au>Shuker, Anthony J</au><au>Rito, Christopher J</au><au>McCarthy, James R</au><au>Ardecky, Robert J</au><au>Tyhonas, John S</au><au>Dana, Sharon L</au><au>Bilakovics, James M</au><au>Paterniti, Jr., James R</au><au>Ogilvie, Kathleen M</au><au>Liu, Sha</au><au>Kauffman, Raymond F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-αγ agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2002-04-01</date><risdate>2002</risdate><volume>51</volume><issue>4</issue><spage>1083</spage><pages>1083-</pages><issn>0012-1797</issn><pub>American Diabetes Association</pub><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0012-1797 |
| ispartof | Diabetes (New York, N.Y.), 2002-04, Vol.51 (4), p.1083 |
| issn | 0012-1797 |
| language | eng |
| recordid | cdi_gale_infotracgeneralonefile_A84721248 |
| source | EZB-FREE-00999 freely available EZB journals |
| subjects | Adipose tissue Adipose tissues Analysis Body weight Cardiovascular diseases Food consumption Genetic aspects Glucose tolerance test Glucose tolerance tests Liver Measurement Metabolism Physiological aspects Risk factors Type 2 diabetes |
| title | A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-αγ agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T22%3A58%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20tailored%20therapy%20for%20the%20metabolic%20syndrome:%20the%20dual%20peroxisome%20proliferator-activated%20receptor-%CE%B1%CE%B3%20agonist%20LY465608%20ameliorates%20insulin%20resistance%20and%20diabetic%20hyperglycemia%20while%20improving%20cardiovascular%20risk%20factors%20in%20preclinical%20models&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=Etgen,%20Garret%20J&rft.date=2002-04-01&rft.volume=51&rft.issue=4&rft.spage=1083&rft.pages=1083-&rft.issn=0012-1797&rft_id=info:doi/&rft_dat=%3Cgale%3EA84721248%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A84721248&rfr_iscdi=true |